Prescribing statins to patients with nonalcoholic fatty liver disease: Real cardiovascular benefits outweigh theoretical hepatotoxic risk
Riley P et al. – A review summarizes the evidence for and against the prescription of statins to pts with nonalcoholic fatty liver disease, a group typically associated with high cardiovascular risk. Methods- Review of evidence for/against statin use in nonalcoholic fatty liver disease
Results- Statins are widely prescribed, with a significant role in reducing cardiovascular risk
- Concern for hepatic safety profile may prevent use for pts with concurrent liver pathology
- Contrary to current opinion, considerable evidence for and little evidence against prescription of statins to this population
- Guidelines advising against statin use in this setting should be reviewed
[more...]
|
|
|
